CD8A and neoplasm: Accordingly, the combinatorial treatment resulted in increased proportions of both CD4+ and CD8+ T cells in the tumor mass (Fig. 6g), where CD8+ T cells also expressed higher levels of the activation marker PD-1 (Fig. 6h) and increased numbers of CD8+ T cells spatially localized in the inner tumor parenchyma (Fig. 6i, j).